DexCom, Inc. vs Natera, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Natera, Inc. is the larger company by market value: $58.7 B against $29.9 B for DexCom, Inc., 2.0 times as much (market caps of Oct 22, 2026 for DexCom, Inc. and Oct 27, 2026 for Natera, Inc.).
- DexCom, Inc. had more revenue: $4.7 B against $2.3 B for Natera, Inc., both in the year to December 2025.
- DexCom, Inc. made a net profit of $836 M, while Natera, Inc. made a net loss of $208 M.
- DexCom, Inc. keeps more of each dollar of sales: a net margin of 17.9% against -9.0% for Natera, Inc.
- DexCom, Inc. employs more people: 11,100 against 3,018 at Natera, Inc. Each employee brings in about $420,000 of revenue at DexCom, Inc. and $764,119 at Natera, Inc.
- Natera, Inc.'s revenue grew faster in its latest fiscal year: +35.9% against +15.6% for DexCom, Inc.
- Both are in the safe zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | DexCom, Inc. DXCM · #853 in the world | Natera, Inc. NTRA · #434 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | 1999 | 2004 |
| Size | ||
| Market cap | $29.9 B | $58.7 B |
| Revenue | $4.7 B | $2.3 B |
| Net income | $836 M▲ best | $-208 M |
| Employees | 11,100 | 3,018 |
| Valuation | ||
| P/E ratio | 30.2× | — |
| Price to sales | 5.9× | 20.2× |
| Price to book | 10.9× | 34.3× |
| Free cash flow yield | 3.6%▲ best | 0.2% |
| Profitability | ||
| Gross margin | 60.1% | — |
| Operating margin | 19.6%▲ best | -13.4% |
| Net margin | 17.9%▲ best | -9.0% |
| Return on equity | 34.5%▲ best | -14.3% |
| Growth | ||
| Revenue growth | 15.6% | 35.9%▲ best |
| Revenue growth, 3 years a year | 17.0% | 41.1%▲ best |
| Earnings per share growth | 47.2% | — |
| Financial strength | ||
| Interest cover | 63.8×▲ best | -76.1× |
| Cash | ||
| Free cash flow margin | 23.1%▲ best | 4.7% |
| Shareholder returns | ||
| Shareholder yield | 1.7% | — |
| Altman Z-score zone | safe | safe |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, DexCom, Inc. or Natera, Inc.?
Natera, Inc. is the larger company by market value: $58.7 B against $29.9 B for DexCom, Inc., 2.0 times as much (market caps of Oct 22, 2026 for DexCom, Inc. and Oct 27, 2026 for Natera, Inc.).
Which makes more money, DexCom, Inc. or Natera, Inc.?
DexCom, Inc. had more revenue: $4.7 B against $2.3 B for Natera, Inc., both in the year to December 2025. DexCom, Inc. made a net profit of $836 M, while Natera, Inc. made a net loss of $208 M.
Which is more profitable, DexCom, Inc. or Natera, Inc.?
DexCom, Inc. keeps more of each dollar of sales: a net margin of 17.9% against -9.0% for Natera, Inc.
Which has more employees, DexCom, Inc. or Natera, Inc.?
DexCom, Inc. employs more people: 11,100 against 3,018 at Natera, Inc. Each employee brings in about $420,000 of revenue at DexCom, Inc. and $764,119 at Natera, Inc.
Which is growing faster, DexCom, Inc. or Natera, Inc.?
Natera, Inc.'s revenue grew faster in its latest fiscal year: +35.9% against +15.6% for DexCom, Inc.
Which is financially stronger, DexCom, Inc. or Natera, Inc.?
Both are in the safe zone of the Altman Z-score.
More about DexCom, Inc.
More about Natera, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.